Journey Medical (DERM) Income from Continuing Operations (2020 - 2026)

Journey Medical has reported Income from Continuing Operations for 7 years, with the latest figure at 2230000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations rose 45.25% year-over-year to 2230000.0; the trailing twelve-month figure through Mar 2026 stood at 9588000.0 (down 16.33% YoY), and the FY2025 full-year result was 11431000.0, up 22.09% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 2230000.0, down from 1247000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 16789000.0 in Q3 2023, with the low at 10642000.0 in Q4 2022.
• Historically, Income from Continuing Operations has averaged 3632529.41 across 5 years, with a median of 3361000.0 in 2024.
• The largest YoY upside for Income from Continuing Operations was 266.56% in 2023 against a maximum downside of 635.56% in 2023.
• Journey Medical's Income from Continuing Operations stood at 10642000.0 in 2022, then jumped by 79.86% to 2143000.0 in 2023, then jumped by 173.82% to 1582000.0 in 2024, then tumbled by 178.82% to 1247000.0 in 2025, then tumbled by 78.83% to 2230000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 2230000.0 (Q1 2026), 1247000.0 (Q4 2025), and 2315000.0 (Q3 2025), per Business Quant data.